Skip to main content
See the bias in every story
Get Started
SubscribeLogin
Published • loading... • Updated

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Summary
Royal Bank Of Canada boosted their price objective on shares of Gilead Sciences from $123.00 to $126.00 and gave the stock a "sector perform" rating in a report on Thursday.

1 Articles

MarketBeatMarketBeat
Center

Gilead Sciences' (GILD) Overweight Rating Reaffirmed at Cantor Fitzgerald

Cantor Fitzgerald reiterated an "overweight" rating and set a $155.00 price objective on shares of Gilead Sciences in a research note on Thursday.

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Thursday, October 8, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Gilead Sciences icon

Gilead Sciences

Stock Markets icon

Stock Markets

Foster City icon

Foster City

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal